1. Home
  2. VUZI vs ENTX Comparison

VUZI vs ENTX Comparison

Compare VUZI & ENTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VUZI
  • ENTX
  • Stock Information
  • Founded
  • VUZI 1997
  • ENTX 2010
  • Country
  • VUZI United States
  • ENTX Israel
  • Employees
  • VUZI N/A
  • ENTX N/A
  • Industry
  • VUZI Industrial Machinery/Components
  • ENTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • VUZI Technology
  • ENTX Health Care
  • Exchange
  • VUZI Nasdaq
  • ENTX Nasdaq
  • Market Cap
  • VUZI 122.9M
  • ENTX 104.0M
  • IPO Year
  • VUZI N/A
  • ENTX 2018
  • Fundamental
  • Price
  • VUZI $2.92
  • ENTX $1.85
  • Analyst Decision
  • VUZI Strong Buy
  • ENTX Strong Buy
  • Analyst Count
  • VUZI 1
  • ENTX 1
  • Target Price
  • VUZI $2.00
  • ENTX $10.00
  • AVG Volume (30 Days)
  • VUZI 2.1M
  • ENTX 39.1K
  • Earning Date
  • VUZI 05-12-2025
  • ENTX 05-09-2025
  • Dividend Yield
  • VUZI N/A
  • ENTX N/A
  • EPS Growth
  • VUZI N/A
  • ENTX N/A
  • EPS
  • VUZI N/A
  • ENTX N/A
  • Revenue
  • VUZI $5,331,630.00
  • ENTX $223,000.00
  • Revenue This Year
  • VUZI $45.35
  • ENTX N/A
  • Revenue Next Year
  • VUZI $54.01
  • ENTX N/A
  • P/E Ratio
  • VUZI N/A
  • ENTX N/A
  • Revenue Growth
  • VUZI N/A
  • ENTX N/A
  • 52 Week Low
  • VUZI $0.83
  • ENTX $1.41
  • 52 Week High
  • VUZI $5.79
  • ENTX $2.79
  • Technical
  • Relative Strength Index (RSI)
  • VUZI 64.46
  • ENTX 39.76
  • Support Level
  • VUZI $2.27
  • ENTX $1.69
  • Resistance Level
  • VUZI $3.00
  • ENTX $2.08
  • Average True Range (ATR)
  • VUZI 0.30
  • ENTX 0.13
  • MACD
  • VUZI 0.06
  • ENTX -0.03
  • Stochastic Oscillator
  • VUZI 71.43
  • ENTX 28.18

About VUZI Vuzix Corporation

Vuzix Corp is engaged in the design, manufacturing, marketing, and selling of Smart Glasses and Augmented Reality (AR) technologies and products for the enterprise, medical, defense, and consumer markets. Its products include head-mounted (or HMDs or heads-up displays or HUDs) smart personal display and wearable computing devices that offer users a portable high-quality viewing experience, provide solutions for mobility, wearable displays, and augmented reality, as well as OEM waveguide optical components and display engines. Geographically, the company generates a majority of its revenue from the United States and also has a presence in Japan, Netherlands, and other countries.

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.

Share on Social Networks: